Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Medical Devices

Illumina’s spatial technology holds potential to transform understanding of various diseases, says GlobalData

Illumina has recently unveiled a groundbreaking spatial transcriptomics technology, slated for commercial release in 2026. This innovative solution is designed to empower researchers to map complex tissues and understand cellular behavior at an unprecedented scale. By providing researchers with advanced tools to study complex tissue structures and cellular interactions, the innovation has the potential to […]
Read more

India diabetes care devices market to record CAGR of around 4% through 2033, forecasts GlobalData

India faces a severe and escalating diabetes burden, driven by rapid urbanization, lifestyle changes, and increased rates of obesity. But with growing awareness, people are getting inclined towards proactive diabetes management through technology adoption and better access to information. Advancements in artificial intelligence (AI)-driven solutions are also expected to enhance diabetes care in the country. […]
Read more

Inari Medical acquisition could provide Stryker with foothold in peripheral vascular market, says GlobalData

Stryker recently announced the completion of the acquisition of Inari Medical, a medical device company specializing in treatment for venous thromboembolism. Acquiring Inari’s portfolio of venous thrombectomy devices could enable Stryker to gain a foothold in the rapidly growing peripheral vascular device market, says GlobalData, a leading data and analytics company. Inari Medical’s portfolio of […]
Read more

BD intent to separate business could allow competitors to rise in IVD test markets, says GlobalData

Becton Dickinson (BD) has recently announced its intent to separate its biosciences and diagnostic solutions business. The biosciences segment includes research instruments and reagents, and single-cell multiomics, while the diagnostic solutions segment consists of microbiology and infectious disease diagnostics. According to the company, the two segments earned over $3 billion in revenue in fiscal 2024. BD’s […]
Read more

Getinge surgical perfusion exit opens opportunities for LivaNova in CPBE market, says GlobalData

Swedish medtech company Getinge’s decision to exit the surgical perfusion business signals a strategic shift toward higher-growth areas like extracorporeal membrane oxygenation (ECMO). This move is set to benefit dominant players like LivaNova, which is well-positioned to capture the market share in the cardiopulmonary bypass equipment (CBPE) sector, which continues to show steady growth driven […]
Read more

India robotic surgical systems market to record 10% CAGR during 2024-36, driven by increasing adoption, says GlobalData

The installation of a surgical robot at the All India Institute of Medical Sciences (AIIMS) in Delhi recently marks a testament to the Indian government’s commitment to narrowing the disparity between public and private healthcare services in terms of quality and technological advancements. In light of this context, the market for robotic surgical systems in […]
Read more

AI-driven virtual care innovations will continue to gain traction to navigate workforce challenges, says GlobalData

With healthcare facilities facing staff shortages and increased patient loads, innovative AI-driven solutions are becoming a necessity. Solutions from companies like Vitalacy, Current Health, and Care.ai, are leveraging artificial intelligence (AI), sensor technology, and real-time monitoring to enhance patient safety and optimize hospital efficiency. As such, AI-driven healthcare innovations will continue to gain traction, helping […]
Read more

India transcatheter aortic valve replacement market to record 24% CAGR during 2024-33, forecasts GlobalData

Heart valve diseases, particularly rheumatic heart disease and degenerative aortic stenosis, remain a major burden in India. It is worsened by socioeconomic challenges and limited healthcare access. Against this backdrop, India’s transcatheter aortic valve replacement (TAVR) market is forecast to register a compound annual growth rate (CAGR) of around 24% between 2024 and 2033, according […]
Read more

AI advancements to accelerate China digital health sector, says GlobalData

China’s rapid advancements in artificial intelligence (AI), underscored by the recent launch of Qwen2.5-Max, Kimi k1.5, and DeepSeek v3, are sparking excitement among AI professionals. This progress is expected to have a considerable impact on multiple industries, including healthcare. Consequently, the Chinese digital health market is likely to see further developments, provided the data security […]
Read more

Contactless vital monitoring to transform digital healthcare, says GlobalData

PanopticAI has revolutionized patient monitoring by developing the world’s first FDA-cleared app for contactless pulse rate measurement. Using remote photoplethysmography (rPPG) algorithms and smartphone cameras, this innovation eliminates the need for costly medical equipment, making healthcare more accessible and scalable, says GlobalData, a leading data and analytics company. With just a 30-second scan, the app […]
Read more

Healthcare companies may be neglecting environmental responsibilities in AI push, says GlobalData

Since US President Trump’s first day in office, he has been rolling back environmental responsibilities, marked by withdrawing the US from the Paris Climate Agreement, which set out guidelines for developed countries to support efforts of developing countries to build clean, climate-resilient futures through financial and technological support. The recent developments in the US may […]
Read more

Trump presidency quickly impacting several areas of healthcare, says GlobalData

US President Donald Trump has recently enacted several significant changes to the country’s healthcare policy, focusing on withdrawing from the World Health Organization (WHO), implementing anti-abortion measures, and initiating a freeze on federal grant funding. These actions have far-reaching implications for various aspects of the healthcare system, including Medicaid, according to GlobalData, a leading data […]
Read more

Lantheus to strengthen position in nuclear imaging agents with recent acquisitions, says GlobalData

The demand for nuclear imaging agents is expected to grow significantly, driven by an aging population and advancements in imaging technologies. The industry is shifting toward more targeted, patient-specific solutions, particularly in neuroimaging and oncology, where early detection and personalized treatment are critical. Lantheus’ acquisition of Life Molecular Imaging and Evergreen Theragnostics will strengthen its […]
Read more

Thyroid Awareness Month highlights importance of early detection and treatment, says GlobalData

Thyroid Awareness Month emphasizes the importance of early detection and effective management of thyroid disorders, which affect millions of people worldwide. By raising awareness and encouraging proactive care, this initiative seeks to improve patient outcomes and foster a better understanding of thyroid health, says GlobalData, a leading data and analytics company. The thyroid, a butterfly-shaped […]
Read more

South Korea bone graft and substitutes market to grow at 4% CAGR through 2033, forecasts GlobalData

The increasing prevalence of orthopaedic conditions such as osteoarthritis, osteoporosis, and trauma-related injuries is driving the need for innovative and efficient bone regeneration solutions. Against this backdrop, South Korea’s bone graft and substitutes market is set to grow at a compound annual growth rate (CAGR) of around 4% through 2033, says GlobalData, a leading data […]
Read more

US pulsed field ablation market revenue surpasses $500 million in 2024, reveals GlobalData

Pulsed field ablation (PFA) is a treatment for atrial fibrillation, an irregular heartbeat disorder, with a lower chance of damaging surrounding structures than previous methods. PFA uses electrical pulses that allow for a more targeted approach in order to only destroy abnormal tissue. PFA revenue exploded in Q1 2024 after FDA approvals for Boston Scientific’s FARAPULSE […]
Read more

AdventHealth and Biofourmis partnership marks pivotal step in expanding whole-person care at home in US, says GlobalData

AdventHealth has recently partnered with Biofourmis to launch the AdventHealth Hospital at Home program in Florida in the US, enabling inpatient-level care for patients in the comfort of their homes. This initiative leverages Biofourmis’ enterprise platform, which combines continuous monitoring, FDA-cleared AI algorithms, and remote clinical care teams to provide personalized, holistic care. The partnership […]
Read more
1 … 6 7 8 9 10 … 50